Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$130,794
+$29,352 QoQ
Shares Held
515
+24.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#4,546
of 4,664 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABOUND FINANCIAL, LLC holds $554,570 across 8 Drug Manufacturers - General names. JNJ ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
150 | $179,914 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
515 | $130,794 | |
| 3 | NVS |
Novartis AG
|
771 | $120,831 | |
| 4 | ABBV |
AbbVie Inc.
|
141 | $35,481 | |
| 5 | MRK |
Merck & Co., Inc.
|
246 | $31,611 | |
| 6 | PFE |
Pfizer Inc
|
1,238 | $29,811 | |
| 7 | AZN |
Astrazeneca PLC
|
100 | $18,962 | |
| 8 | SNY |
Sanofi
|
168 | $7,166 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,794 | 515 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $101,442 | 415 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $85,884 | 415 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $68,823 | 415 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||